bioRxivImmunology
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism
L. Simula, V. Cancila, Y. Antonucci, A. Colamatteo, C. Procaccini, G. Matarese, C. Tripodo, S. Campello
Abstract
PD-1 signalling downregulates the T cell response, promoting an exhausted state in tumor-infiltrating T cells, through mostly unveiled molecular mechanisms. Drp1-dependent mitochondrial fission plays a crucial role to sustain T cell motility, proliferation, survival and glycolytic engagement and, interestingly, such processes are exactly those inhibited by PD-1 in tumor-infiltrating T cells. Here we show that the signature of PD-1pos CD8+ T cells infiltrating MC38-derived murine tumor mass is having downregulated Drp1 activity and more fused mitochondria, compared to PD-1neg counterparts. Also, PD-1pos lymphocytic elements infiltrating human colon cancer rarely express active Drp1. Mechanistically, PD-1 signalling directly prevents mitochondria fragmentation following T cell stimulation by downregulating Drp1 phosphorylation on Ser616, via regulation of the ERK1/2 and mTOR pathways. In addition, downregulation of Drp1 activity in tumor-infiltrating PD-1pos CD8+ T cells seems to be a mechanism exploited by PD-1 signalling to reduce motility and proliferation of these cells. Overall, our data indicate that the modulation of Drp1 activity in tumor-infiltrating T cells may become a valuable target to ameliorate the anti-cancer immune response in future immunotherapy approaches.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and tumor target cells within the tumor
R. Ambler, G. L. Edmunds, … C. Wuelfing·bioRxiv·Oct 16, 2018
- Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
T. Honjo, A. Kumar, … P. S. Chowdhury·bioRxiv·Oct 21, 2019
- Dendritic cell PD-L2 restrains intratumoral CD8+ T cell immunity
Jinwoo Nah, Amanda Sun, … Chrysothemis C. Brown·bioRxiv·Sep 16, 2026
- PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunity
Zhiming Mao, Jacob B. Hirdler, … Haidong Dong·bioRxiv·Jan 18, 2025
- PSGL-1 directs early TCR signaling to repress metabolism and promote T cell exhaustion by modulating the TCF-1/TOX axis in CD8+ T cells.
J. L. Hope, D. C. Otero, … L. M. Bradley·bioRxiv·Jan 24, 2022
- PD-1 blockade-driven anti-tumor CD8+ T cell immunity requires XCR1+ dendritic cells
T. Mao, E. Song, A. Iwasaki·bioRxiv·Apr 28, 2020